Schwartz JC - Search Results

1

Iodoaminopotentidine and related compounds: a new class of ligands with high affinity and selectivity for the histamine H2 receptor.

Hirschfeld J, Buschauer A, Elz S, Schunack W, Ruat M, Traiffort E, Schwartz JC. Hirschfeld J, et al. Among authors: schwartz jc. J Med Chem. 1992 Jun 12;35(12):2231-8. doi: 10.1021/jm00090a013. J Med Chem. 1992. PMID: 1613748

2

Development of a new class of nonimidazole histamine H(3) receptor ligands with combined inhibitory histamine N-methyltransferase activity.

Apelt J, Ligneau X, Pertz HH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H. Apelt J, et al. Among authors: schwartz jc. J Med Chem. 2002 Feb 28;45(5):1128-41. doi: 10.1021/jm0110845. J Med Chem. 2002. PMID: 11855993

3

Piperidino-hydrocarbon compounds as novel non-imidazole histamine H(3)-receptor antagonists.

Meier G, Ligneau X, Pertz HH, Ganellin CR, Schwartz JC, Schunack W, Stark H. Meier G, et al. Among authors: schwartz jc. Bioorg Med Chem. 2002 Aug;10(8):2535-42. doi: 10.1016/s0968-0896(02)00115-3. Bioorg Med Chem. 2002. PMID: 12057642

4

Influence of bulky substituents on histamine h(3) receptor agonist/antagonist properties.

Sasse A, Ligneau X, Rouleau A, Elz S, Ganellin CR, Arrang JM, Schwartz JC, Schunack W, Stark H. Sasse A, et al. Among authors: schwartz jc. J Med Chem. 2002 Aug 29;45(18):4000-10. doi: 10.1021/jm020910m. J Med Chem. 2002. PMID: 12190321

5

Novel nonimidazole histamine H3 receptor antagonists: 1-(4-(phenoxymethyl)benzyl)piperidines and related compounds.

Mikó T, Ligneau X, Pertz HH, Ganellin CR, Arrang JM, Schwartz JC, Schunack W, Stark H. Mikó T, et al. Among authors: schwartz jc. J Med Chem. 2003 Apr 10;46(8):1523-30. doi: 10.1021/jm021084k. J Med Chem. 2003. PMID: 12672253

6

Structural variations of 1-(4-(phenoxymethyl)benzyl)piperidines as nonimidazole histamine H3 receptor antagonists.

Mikó T, Ligneau X, Pertz HH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H. Mikó T, et al. Among authors: schwartz jc. Bioorg Med Chem. 2004 May 15;12(10):2727-36. doi: 10.1016/j.bmc.2004.03.009. Bioorg Med Chem. 2004. PMID: 15110854

7

4-(omega-(alkyloxy)alkyl)-1H-imidazole derivatives as histamine H(3) receptor antagonists/agonists.

Meier G, Krause M, Hüls A, Ligneau X, Pertz HH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H. Meier G, et al. Among authors: schwartz jc. J Med Chem. 2004 May 6;47(10):2678-87. doi: 10.1021/jm031065q. J Med Chem. 2004. PMID: 15115409

8

Synthesis, absolute configuration, stereoselectivity, and receptor selectivity of (alpha R, beta S)-alpha,beta-dimethylhistamine, a novel high potent histamine H3 receptor agonist.

Lipp R, Arrang JM, Garbarg M, Luger P, Schwartz JC, Schunack W. Lipp R, et al. Among authors: schwartz jc. J Med Chem. 1992 Nov 13;35(23):4434-41. doi: 10.1021/jm00101a021. J Med Chem. 1992. PMID: 1280301

9

[125I]iodoproxyfan and related compounds: a reversible radioligand and novel classes of antagonists with high affinity and selectivity for the histamine H3 receptor.

Stark H, Purand K, Hüls A, Ligneau X, Garbarg M, Schwartz JC, Schunack W. Stark H, et al. Among authors: schwartz jc. J Med Chem. 1996 Mar 15;39(6):1220-6. doi: 10.1021/jm9504767. J Med Chem. 1996. PMID: 8632428

10

Novel carbamates as potent histamine H3 receptor antagonists with high in vitro and oral in vivo activity.

Stark H, Purand K, Ligneau X, Rouleau A, Arrang JM, Garbarg M, Schwartz JC, Schunack W. Stark H, et al. Among authors: schwartz jc. J Med Chem. 1996 Mar 1;39(5):1157-63. doi: 10.1021/jm9507688. J Med Chem. 1996. PMID: 8676353

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

678 results

Search Page

Filters